Carregant...
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances anti-tumor efficacy in prostate cancer
Prostate cancer is one of the most prevalent cancers in men. Replication-competent oncolytic herpes simplex virus (oHSV) vectors are a powerful anti-tumor therapy that can exert at least two effects: direct cytocidal activity that selectively kills cancer cells and induction of anti-tumor immunity....
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3243306/ https://ncbi.nlm.nih.gov/pubmed/20220784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2010.20 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|